PPD is the ideal consulting partner to assist with your biopharmaceutical product’s success from preclinical through post-approval.
Extensive knowledge of hematology and oncology research, vast capabilities and experience with feasibility studies and a large investigator network.
PPD's Phase I Clinic conducts clinical studies to determine how new medicines act in the bodies of healthy volunteers.
PPD News and Events Media kit
Adalberto Barba Jr., director of clinical operations, early development, at PPD’s clinical pharmacology unit in Las Vegas, Nev., discusses the site’s capabilities in glucose clamp studies.
A new way of thinking about clinical development and delivery
Brian Brogan, senior logistics manager, provides guidance for clinical trial supply chain requirements post-Brexit and offers some practical solutions for affected U.K.-based life science companies.
Giovanni Monopoli, senior project manager, reflects on what he learned about the eligibility criteria at an American Society of Clinical Oncology (ASCO) conference presentation in 2017.
In the final of a four-part series, Jai Balkissoon, vice president of global product development, writes about the challenges in developing immuno-oncology therapies in combination clinical trials.
We want to hear from you
Register in PPD's Database
© 2019 Pharmaceutical Product Development, LLC. All rights reserved.